Intelligence Driven Advisers LLC lessened its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 12.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 5,237 shares of the medical device company’s stock after selling 755 shares during the period. Intelligence Driven Advisers LLC’s holdings in […]
Savant Capital LLC decreased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,120 shares of the medical device company’s stock after selling 3,941 shares during the […]
DexCom (NASDAQ:DXCM – Get Free Report) had its price objective raised by equities researchers at Canaccord Genuity Group from $144.00 to $145.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the medical device company’s stock. Canaccord Genuity Group’s price target points to a potential upside of […]
DexCom (NASDAQ:DXCM – Get Free Report) had its target price lifted by research analysts at Raymond James from $151.00 to $160.00 in a research report issued on Friday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical device company’s stock. Raymond James’ price target points to a potential upside of 28.68% from […]
DexCom (NASDAQ:DXCM – Get Free Report) released its quarterly earnings data on Thursday. The medical device company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05, reports. DexCom had a return on equity of 31.38% and a net margin of 16.82%. The firm had revenue of $921.00 million […]